Tasurgratinib（E7090)

SKU: orb3032937

Description

E7090 (E 7090) is a highly potent and selective orally bioavailable inhibitor targeting FGFR1, FGFR2, and FGFR3, with IC50 values of 0.71 nM, 0.50 nM, and 1.2 nM, respectively. It exhibits significantly weaker inhibition of FGFR4, with an IC50 of 120 nM. This distinct selectivity profile positions E7090 as a promising therapeutic candidate for diseases driven by aberrant FGFR1-3 signaling, offering a targeted approach to inhibit these receptors while minimizing off-target effects on FGFR4. Its oral availability further enhances its potential as a convenient and effective treatment option for patients with FGFR-dependent conditions.

Key Properties

• CAS Number: 1622204-21-0
• MW: 587.677
• Purity: >98%
• Formula: C₃₂H₃₇N₅O₆

Storage & Handling

• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only